Patents by Inventor Shunichi Akiba

Shunichi Akiba has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ?-glucuronidase inhibitor
    Patent number: 9200269
    Abstract: Provided are a novel ?-glucuronidase inhibitor including a compound selected from a macrocyclic ketone, a ketone, a macrocyclic lactone, a macrocyclic oxalactone, an ester, an aldehyde, an alcohol, and a terpene of specific kinds, and an environmental hygiene product and a sanitary product each containing the ?-glucuronidase inhibitor. Also provided are a composition for suppressing the generation of urine odor and a method of suppressing the generation of urine odor each using a ?-glucuronidase inhibitor.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: December 1, 2015
    Assignee: KAO CORPORATION
    Inventors: Ichiro Mori, Shunichi Akiba
  • BETA-GLUCURONIDASE INHIBITOR
    Publication number: 20100247475
    Abstract: Provided are a novel ?-glucuronidase inhibitor including a compound selected from a macrocyclic ketone, a ketone, a macrocyclic lactone, a macrocyclic oxalactone, an ester, an aldehyde, an alcohol, and a terpene of specific kinds, and an environmental hygiene product and a sanitary product each containing the ?-glucuronidase inhibitor. Also provided are a composition for suppressing the generation of urine odor and a method of suppressing the generation of urine odor each using a ?-glucuronidase inhibitor.
    Type: Application
    Filed: September 19, 2008
    Publication date: September 30, 2010
    Applicant: KAO CORPORATION
    Inventors: Ichiro Mori, Shunichi Akiba
  • Deodorant composition
    Patent number: 7501136
    Abstract: Provided is a deodorant composition containing (A) an extract of a plant selected from phellodendron (Phellodendron amurense or P. chinensis), ginkgo (Ginkgo biloba), Lithospermum erythrorhizon, licorice (Glycyrrhiza glabra) and gardenia (Gardenia jasminoides), and (B) an unsaturated fatty acid. This deodorant composition has benefits such as an excellent deodorant effect and even if it contains powder, it does not leave substantially any white residue on the skin.
    Type: Grant
    Filed: September 27, 2004
    Date of Patent: March 10, 2009
    Assignee: Kao Corporation
    Inventors: Toyoki Hagura, Akira Fuji, Shunichi Akiba, Hiroshi Kusuoku
  • Apolipoprotein D degradation inhibitor
    Patent number: 7078437
    Abstract: The invention contemplates drugs useful for maintenance or promotion at sites of regenerating nerves and for prevention or treatment of pathological conditions caused by denaturation or cell damage in the nervous system. Thus, the invention provides an apolipoprotein D degradation inhibitor containing lauric acid or oleic acid as an active ingredient.
    Type: Grant
    Filed: July 27, 2004
    Date of Patent: July 18, 2006
    Assignee: Kao Corporation
    Inventors: Shunichi Akiba, Katsutoshi Ara, Hiroshi Kusuoku, Yoshinori Nishizawa
  • Deodorant composition
    Publication number: 20050100520
    Abstract: Provided is a deodorant composition containing (A) an extract of a plant selected from phellodendron (Phellodendron amurense or P. chinensis), ginkgo (Ginkgo biloba), Lithospermum erythrorhizon, licorice (Glycyrrhiza glabra) and gardenia (Gardenia jasminoides), and (B) an unsaturated fatty acid. This deodorant composition has benefits such as an excellent deodorant effect and even if it contains powder, it does not leave substantially any white residue on the skin.
    Type: Application
    Filed: September 27, 2004
    Publication date: May 12, 2005
    Applicant: KAO CORPORATION
    Inventors: Toyoki Hagura, Akira Fuji, Shunichi Akiba, Hiroshi Kusuoku
  • Apolipoprotein D degradation inhibitor
    Publication number: 20050049308
    Abstract: The invention contemplates drugs useful for maintenance or promotion at sites of regenerating nerves and for prevention or treatment of pathological conditions caused by denaturation or cell damage in the nervous system. Thus, the invention provides an apolipoprotein D degradation inhibitor containing lauric acid or oleic acid as an active ingredient.
    Type: Application
    Filed: July 27, 2004
    Publication date: March 3, 2005
    Applicant: KAO CORPORATION
    Inventors: Shunichi Akiba, Katsutoshi Ara, Hiroshi Kusuoku, Yoshinori Nishizawa
  • Citral acetal
    Patent number: 6506793
    Abstract: The present invention provides a citral acetal capable of sustaining a lemon aroma unique to citral and a perfume composition comprising the citral acetal, as well as an LDH inhibitor and a deodorant, cosmetics and a skin agent for external application, comprising the LDH inhibitor. The citral acetal of the present invention is represented by formula (1): wherein the wavy line represents a cis and/or trans form, and R represents a C1, to C9, linear or branched alkyl group.
    Type: Grant
    Filed: October 10, 2001
    Date of Patent: January 14, 2003
    Assignee: Kao Corporation
    Inventors: Sakuya Tanaka, Shigeyoshi Tanaka, Shunichi Akiba, Katsutoshi Ara, Hirohiko Ishida
  • Citral Acetal
    Publication number: 20020068075
    Abstract: The present invention provides a citral acetal capable of sustaining a lemon aroma unique to citral and a perfume composition comprising the citral acetal, as well as an LDH inhibitor and a deodorant, cosmetics and a skin agent for external application, comprising the LDH inhibitor.
    Type: Application
    Filed: October 10, 2001
    Publication date: June 6, 2002
    Applicant: Kao Corporation
    Inventors: Sakuya Tanaka, Shigeyoshi Tanaka, Shunichi Akiba, Katsutoshi Ara, Hirohiko Ishida